KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to -$174.0 million.

  • Amgen's Change in Account Payables fell 4262.3% to -$174.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $680.0 million, marking a year-over-year increase of 9047.62%. This contributed to the annual value of $312.0 million for FY2024, which is 17761.19% up from last year.
  • As of Q3 2025, Amgen's Change in Account Payables stood at -$174.0 million, which was down 4262.3% from $589.0 million recorded in Q2 2025.
  • In the past 5 years, Amgen's Change in Account Payables registered a high of $643.0 million during Q2 2024, and its lowest value of -$253.0 million during Q1 2023.
  • Its 5-year average for Change in Account Payables is $47.7 million, with a median of -$44.0 million in 2022.
  • Per our database at Business Quant, Amgen's Change in Account Payables plummeted by 84285.71% in 2021 and then soared by 206086.96% in 2025.
  • Amgen's Change in Account Payables (Quarter) stood at $191.0 million in 2021, then surged by 54.97% to $296.0 million in 2022, then plummeted by 163.18% to -$187.0 million in 2023, then fell by 24.06% to -$232.0 million in 2024, then grew by 25.0% to -$174.0 million in 2025.
  • Its Change in Account Payables was -$174.0 million in Q3 2025, compared to $589.0 million in Q2 2025 and $497.0 million in Q1 2025.